Clarification of Research Strategy Structure for PAR-20-105 "Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed."
Release Date: March 11, 2020
FOOD AND DRUG ADMINISTRATION (FDA)
The purpose of this notice is clarify the content of the Research Strategy section to PAR-20-105 "Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed.”
To allow applicants the full maximum 12 pages for the Research Strategy,
- The assessment, when applicable, must be uploaded to line item 4, Progress Report Publication List, on the PHS398 Research Plan form. Each assessment, depending on the Analytical Track, is between 1-3 pages. The page limit for the Research Strategy for each project is 12 pages.
- Facility diagrams including the location of equipment should be uploaded to line item 10. Facilities & Other Resources on the Research & Related Other Project Information form. Pictures are acceptable if they are labeled to describe the layout in the way that a diagram/sketch would. Please be mindful that any attachments must be in a PDF file format.
- Details about the major items of equipment already available for this project and pertinent capabilities should be uploaded to line item 11. Equipment on the Research & Related Other Project Information form.
Please visit www.grants.gov PAR-20-105 Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed Related Documents for Q&A's.
Please direct all inquiries to:
Grants Management Specialist
Office of Operations, Office of Finance Budget & Acquisitions
Office of Acquisitions and Grants Services, HFA-500
U.S. Food and Drug Administration